U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details


Last Revision: September 15, 2023.

Estimated reading time: 1 minute

CASRN: 55981-09-4

image 135002935 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Limited information indicates that a maternal dose of 500 mg of nitazoxanide produces low levels of an active metabolite, tizoxanide, in breastmilk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. But until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

After oral administration, nitazoxanide is not found in the bloodstream, but is rapidly converted to the active metabolites, tizoxanide and tizoxanide glucuronide, which are detectable in plasma.

Maternal Levels. A volunteer lactating mother took a single 500 mg oral dose of nitazoxanide as a commercial suspension (Nitazode, Al Andalous Medical Co., Cairo, Egypt). The concentration of the active metabolite, tizoxanide, was 1.4 mg/L at 6 hours after the dose. Tizoxanide glucuronide was not measured.[1]

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.


Hadad GM, Abdel Salam, RA, Emara S. Validated and optimized high-performance liquid chromatographic determination of tizoxanide, the main active metabolite of nitazoxanide in human urine, plasma and breast milk. J Chromatogr Sci 2012;50:509-15. [PubMed: 22525879]

Substance Identification

Substance Name


CAS Registry Number


Drug Class

Breast Feeding


Milk, Human

Anti-Infective Agents

Antiparasitic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK500567PMID: 29999627


Related information

Similar articles in PubMed

  • Review Nizatidine.[Drugs and Lactation Database (...]
    Review Nizatidine.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Acebutolol.[Drugs and Lactation Database (...]
    Review Acebutolol.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Prilocaine.[Drugs and Lactation Database (...]
    Review Prilocaine.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Moclobemide.[Drugs and Lactation Database (...]
    Review Moclobemide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Salsalate.[Drugs and Lactation Database (...]
    Review Salsalate.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...